Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). - Test2 - elhamkhani - TriplyDB

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).

http://www.wikidata.org/entity/Q33770863

about

Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?IL-1β and IL-6 Are Highly Expressed in RF+IgE+ Systemic Lupus Erythematous Subtype Current serological possibilities for the diagnosis of arthritis with special focus on proteins and proteoglycans from the extracellular matrix.The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.How common is remission in juvenile idiopathic arthritis: A systematic review.Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study.Clinical Outcome and Long-term Remission in JIA.

P2860

Q37093920-1EFC1A80-FE84-4162-B582-701C8BC10443 Q37670861-D14EA04E-EA05-4C88-B3CA-CEAD127A22A0 Q38266373-49257128-D74D-47C5-B3E7-130810DB0F09 Q38661867-1DEFB414-BD12-46BF-B32A-78E7848E235D Q38720413-61900084-D2A0-4A92-9C39-BD3BB5D87D97 Q40709078-C905D087-1C5C-4498-A4E4-0F7B57F42102 Q50171622-FB7C0512-AEB6-4E4D-97A0-98A25A7A47F1

P2860

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).

http://www.wikidata.org/entity/Q33770863

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-type II collagen antibodi ...... le idiopathic arthritis (JIA).

@ast

Anti-type II collagen antibodi ...... le idiopathic arthritis (JIA).

@en

type

label

Anti-type II collagen antibodi ...... le idiopathic arthritis (JIA).

@ast

Anti-type II collagen antibodi ...... le idiopathic arthritis (JIA).

@en

prefLabel

Anti-type II collagen antibodi ...... le idiopathic arthritis (JIA).

@ast

Anti-type II collagen antibodi ...... le idiopathic arthritis (JIA).

@en

P1433

Q33770863-DF833697-55A2-4447-8699-80C9242EF214

P1476

Q33770863-779820D3-4FAD-49E2-AF2D-73C4740C4C57

P2093

Q33770863-0829E3CE-6F2D-46DA-B20F-4EA7DDD11720

Q33770863-0AA12C1B-F541-49E2-8AC1-B1433797810A

Q33770863-6370C79B-EB21-4FA5-8555-4116B65DCA46

Q33770863-6EC9EC95-420D-4CBC-9A85-AE0D35422CE2

Q33770863-B9D2A6D4-94DB-4C84-B5D2-45A504E3C095

Q33770863-C0C5EE49-B4CD-4661-9E72-E07EA98C5032

Q33770863-CA6C2BBA-1EC8-42E4-B9E5-32412D574AFF

Q33770863-EEB9E684-5DAB-4C7E-A3EC-906F7147636E

P2860

Q33770863-0376F2B9-6586-41DC-A698-91B3D449CED4

Q33770863-09BFE2ED-9CF3-4975-8585-6CCA0F3CE504

Q33770863-1850AFD5-3108-447E-9864-64EC48D60CEE

Q33770863-1AEC884A-86E8-43F1-819D-374BA73CD7EF

Q33770863-1D6FC8F8-D494-41A8-B077-F2CCD731C095

Q33770863-1F6372E7-C7E7-4AED-99BE-D5265D7FBBEA

Q33770863-24512BE8-366A-49D7-BF70-6A41F83D39C0

Q33770863-29983115-15BE-4418-ADE9-97E4E358E184

Q33770863-2F6383C7-B086-44FF-9AF1-5E49E51603E0

Q33770863-389DCDA4-68DA-4FD9-934D-77F7C2D4381A

P2888

Q33770863-3490FECB-A792-4FBF-91A6-B0EDF7E33A70

P304

Q33770863-80415C22-C8AC-4D77-9547-E2E18F2A5581

P31

Q33770863-57201ED1-AF71-4E28-A767-B83F217602D5

P356

Q33770863-2FD301A3-D088-4CB4-B4E8-BFE9C17DFD1B

P478

Q33770863-85C28A50-D175-44C3-8BA2-D5C0BD47F96B

P50

Q33770863-48407E63-869C-44FD-A58D-DA926FCE178E

Q33770863-BE68142E-E5FE-413F-8D63-8D076DC8CF1F

P577

Q33770863-39D1B1FF-0CF5-4F88-B0A2-E4170EFA58A6

P5875

Q33770863-D56102E1-464C-4501-99B8-68FA121736E4

P6179

Q33770863-639DC572-4A5B-495A-9871-8F2FEC00ABE5

P698

Q33770863-4F2CB3BF-5257-4AA9-9DA2-4A50DC5D6A02

P921

Q33770863-8F7BD658-0543-4DD0-8A77-2262DD0DD8C2

P932

Q33770863-927D6C66-E10F-4615-B8C0-876C0111280C

P356

1546-0096-12-22

P1433

Pediatric Rheumatology Online Journal

P1476

Anti-type II collagen antibodi ...... le idiopathic arthritis (JIA).

@en

P2093

Anders Fasth

http://www.w3.org/2001/XMLSchema#string

Johan Rönnelid

http://www.w3.org/2001/XMLSchema#string

Kristiina Aalto

http://www.w3.org/2001/XMLSchema#string

Marek Zak

http://www.w3.org/2001/XMLSchema#string

Marite Rygg

http://www.w3.org/2001/XMLSchema#string

Nordic Study Group of Pediatric Rheumatology (NoSPeR)

http://www.w3.org/2001/XMLSchema#string

Susan Nielsen

http://www.w3.org/2001/XMLSchema#string

Troels Herlin

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides

Antibodies against native type II collagen do not precede the clinical onset of rheumatoid arthritis.

Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression.

Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis

P2888

1546-0096-12-22

P304

22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1546-0096-12-22

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ellen Berit Nordal

Lillemor Berntson

P577

2014-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263291560

http://www.w3.org/2001/XMLSchema#string

P6179

1047671279

http://www.w3.org/2001/XMLSchema#string

P698

24944545

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis

P932

4061516

http://www.w3.org/2001/XMLSchema#string